We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
-0.2%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$147B
AUM Growth
+$7.72B
Cap. Flow
+$9.46B
Cap. Flow %
6.42%
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131

Sector Composition

Rank Sector Weight
1 Technology 8.02%
2 Financials 3.7%
3 Industrials 2.22%
4 Healthcare 2.17%
5 Consumer Discretionary 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATLX icon
3976
Atlas Lithium Corp
ATLX
$84M
$54.5K ﹤0.01%
12,525
CLIR icon
3977
ClearSign Technologies
CLIR
$21.4M
$53.9K ﹤0.01%
12,355
-1,250
-9% -$7.17K
TCPC icon
3978
BlackRock TCP Capital
TCPC
$265M
$53.1K ﹤0.01%
14,715
+3,461
+31% +$16.1K
BRK.B icon
3979
PUT
Berkshire Hathaway Class B
BRK.B
$1.07T
$53.1K ﹤0.01%
12,000
ORGO icon
3980
Organogenesis Holdings
ORGO
$306M
$53K ﹤0.01%
22,355
-13,229
-37% -$45.8K
INV
3981
Innventure Inc
INV
$245M
$51.6K ﹤0.01%
+13,191
New +$46.6K
BZAIW
3982
Blaize Holdings Warrants
BZAIW
$6.69M
$51.2K ﹤0.01%
134,700
AAPL icon
3983
PUT
Apple
AAPL
$4.89T
$50.6K ﹤0.01%
41,500
-13,900
-25% -$3.62M
CDZI icon
3984
Cadiz
CDZI
$266M
$50K ﹤0.01%
+10,185
New +$55.7K
CTMX icon
3985
CytomX Therapeutics
CTMX
$708M
$49.4K ﹤0.01%
+10,505
New +$53.3K
ALDX icon
3986
Aldeyra Therapeutics
ALDX
$91.1M
$48.8K ﹤0.01%
28,871
-5,650
-16% -$24.8K
NGEN
3987
NervGen Pharma
NGEN
$178M
$48.8K ﹤0.01%
+12,937
New +$56K
IHRT icon
3988
iHeartMedia
IHRT
$555M
$47.8K ﹤0.01%
16,382
-10,377
-39% -$34.3K
SCHW
3989
PUT
Charles Schwab
SCHW
$177B
$47.8K ﹤0.01%
20,000
OCGN icon
3990
Ocugen
OCGN
$423M
$47.2K ﹤0.01%
26,087
+4,125
+19% +$7.13K
GDRX icon
3991
GoodRx Holdings
GDRX
$982M
$46.3K ﹤0.01%
23,624
+2,515
+12% +$5.9K
SLI
3992
Standard Lithium
SLI
$524M
$45K ﹤0.01%
+13,201
New +$59.1K
AIV
3993
Aimco
AIV
$381M
$43.4K ﹤0.01%
10,666
-2,005
-16% -$10.5K
BZAI
3994
Blaize Holdings
BZAI
$134M
$43K ﹤0.01%
+23,600
New +$34.8K
VTEX icon
3995
VTEX
VTEX
$675M
$42.6K ﹤0.01%
+10,645
New +$37.2K
ACB
3996
Aurora Cannabis
ACB
$165M
$42.4K ﹤0.01%
+12,953
New +$48.9K
TTGT icon
3997
TechTarget
TTGT
$250M
$41.8K ﹤0.01%
10,779
-21,152
-66% -$97.3K
TUSK icon
3998
Mammoth Energy Services
TUSK
$134M
$41.5K ﹤0.01%
16,950
+4,844
+40% +$11K
GOSS icon
3999
Gossamer Bio
GOSS
$66.2M
$41.3K ﹤0.01%
125,627
+80,016
+175% +$126K
NAK
4000
Northern Dynasty Minerals
NAK
$891M
$41K ﹤0.01%
29,265
-3,780
-11% -$6.57K

Similar funds

Creative Planning's Q1 2026 Portfolio in Review

As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Creative Planning deployed $9.46B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 8.4% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.

  • Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
  • Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
  • Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
  • Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
  • Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
  • Creative Planning opened 328 new positions and closed 131 in Q1 2026.
  • Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.